Autolus Therapeutics plc (6A3A) — Net Asset Quality Index
Autolus Therapeutics plc (6A3A) has a Net Asset Quality Index of 15.2% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €493.23 Million minus total liabilities of €418.39 Million yields net assets of €74.84 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Autolus Therapeutics plc (6A3A) total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Autolus Therapeutics plc Net Asset Quality Index Over Time (2017–2025)
This chart shows how Autolus Therapeutics plc's Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the index stands at 15.2%, representing net assets of €74.84 Million against total assets of €493.23 Million EUR. For live market cap and overall valuation, see 6A3A market cap.
Annual Net Asset Quality Index for Autolus Therapeutics plc (2017–2025)
The table below presents the year-by-year Net Asset Quality Index for Autolus Therapeutics plc from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Autolus Therapeutics plc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 30.2% | €178.13 Million | €589.07 Million | €410.94 Million | ▼ -24.4 pp |
| 2024 | 54.6% | €427.32 Million | €782.73 Million | €355.40 Million | ▲ +24.9 pp |
| 2023 | 29.7% | €111.47 Million | €375.38 Million | €263.91 Million | ▼ -31.2 pp |
| 2022 | 60.9% | €298.67 Million | €490.27 Million | €191.60 Million | ▼ -16.3 pp |
| 2021 | 77.3% | €313.32 Million | €405.56 Million | €92.24 Million | ▲ +5.9 pp |
| 2020 | 71.4% | €210.03 Million | €294.24 Million | €84.20 Million | ▼ -12.6 pp |
| 2019 | 84.0% | €254.84 Million | €303.53 Million | €48.69 Million | ▼ -9.5 pp |
| 2018 | 93.5% | €255.47 Million | €273.20 Million | €17.74 Million | ▼ -2.4 pp |
| 2017 | 95.9% | €142.60 Million | €148.66 Million | €6.06 Million | — |